This prospective multicenter study based on endoscopic monitoring of patients following treatment of Type 1 G-NETs with argon plasma ablation shows that this procedure is safe and effective.
En la evaluación de los pacientes con recurrencia se encontró que la atrofia severa y la anemia 75% son factores de riesgo para recurrencia 85,7%.